Nidufexor

DB16255InvestigationalSmall molecule

Nidufexor is under investigation in clinical trial NCT03804879 (Safety, Tolerability and Efficacy of LMB763 in Patients With Diabetic Nephropathy).

Chemical structure of Nidufexor
Mechanism
Curator reviewed
Formula / weight
C27H22ClN3O4 · 487.94 g/mol (avg)
Code names
LMB763

Resolves to

Compound
UNIICJ1PL0TE6JCAS1773489-72-7ChEMBLCHEMBL4297626
Structure
InChIKeyJYTIXGYXBIBOMN-UHFFFAOYSA-NSMILESCN1N=C(C(=O)N(CC2=CC=CC=C2)CC2=CC=C(C=C2)C(O)=O)C2=C1C1=C(OC2)C=CC(Cl)=C1
Targets
Q96RI1NR1H4

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Nidufexor, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In